Null hypothesis (H0) | Total number of patients required | Number of responses needed for H0 rejection | Alternative hypothesis | Type I error | power | |
---|---|---|---|---|---|---|
Cervical cancer | π > 10% | 18 | 5 | π =35% | 5% | 80% |
Endometrial carcinoma | π > 10% | 25 | 6 | π =30% | 5% | 79.3% |
Uterine sarcoma | No sample size calculation is performed due to the rarity of the disease, but these patients will be allowed on the study |